Shukra [SHUKRAPHAR] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Shukra Pharmaceuticals Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shukra Pharmaceuticals Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. Shukra Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Shukra Pharmaceuticals Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 770.20 -13.65 Shukra Pharmaceuticals Ltd.
Price-to-Book Ratio 22.86 -13.55 Shukra Pharmaceuticals Ltd.
Debt-to-Equity Ratio 5.71 -1.21 Shukra Pharmaceuticals Ltd.
PEG Ratio 1.39 -11.15 Shukra Pharmaceuticals Ltd.
EV/EBITDA 34.62 -22.27 Shukra Pharmaceuticals Ltd.
Profit Margin (TTM) 45.16% -53.22% Shukra Pharmaceuticals Ltd.
Operating Margin (TTM) 67.87% -700.71% Shukra Pharmaceuticals Ltd.
EBITDA Margin (TTM) 67.87% N/A N/A
Return on Equity 15.24% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 11.04% -102.08% Shukra Pharmaceuticals Ltd.
Free Cash Flow (TTM) $51.75M $-3.71B Shukra Pharmaceuticals Ltd.
Dividend Yield 3.20% N/A N/A
1-Year Return 118.63% 14.56% Shukra Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 21.46 87.98 Shukra Pharmaceuticals Ltd.
Enterprise Value $13.61B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 21.08 95.73 Shukra Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 81.77% -59.53% Shukra Pharmaceuticals Ltd.
Revenue per Share (TTM) $1 $2 Sun Pharma Advanced Research Company Ltd.
Earnings per Share (Diluted) $-0.20 $-8.25 Shukra Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.94 0.19 Sun Pharma Advanced Research Company Ltd.

Shukra Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

SHUKRAPHAR
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shukra Pharmaceuticals Ltd.-0.62%6.94%-4.52%-25.68%-25.03%-48.27%
Sun Pharma Advanced Research Company Ltd.2.09%-13.30%46.20%62.20%26.84%51.26%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shukra Pharmaceuticals Ltd.118.63%781.16%1,678.53%1,807.24%681.40%681.40%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Shukra Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricSHUKRAPHARSPARC
Market Information
Market Cap i₹13.91B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i458,4252,401,062
90 Day Avg. Volume i341,8122,083,443
Last Close₹28.94₹208.50
52 Week Range₹12.97 - ₹65.26₹108.00 - ₹248.75
% from 52W High-55.65%-16.18%
All-Time High₹65.26 (Dec 19, 2025)₹875.00 (Apr 24, 2006)
% from All-Time High-55.65%-76.17%
Growth Metrics
Quarterly Revenue Growth2.45%-0.43%
Quarterly Earnings Growth5.44%-0.43%
Financial Health
Profit Margin (TTM) i0.45%-0.53%
Operating Margin (TTM) i0.68%-7.01%
Return on Equity (TTM) i0.15%1.58%
Debt to Equity (MRQ) i5.71-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹1.38₹-10.63
Cash per Share (MRQ)₹0.31₹0.03
Operating Cash Flow (TTM) i₹66.80M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹95.75M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i3.20%N/A
Last 12-Month Dividend i₹1.02N/A

Valuation & Enterprise Metrics Analysis: Shukra Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricSHUKRAPHAR (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i770.20-13.65
Forward P/E iN/A2.60
PEG Ratio i1.39-11.15
Price to Sales (TTM) i21.4687.98
Price to Book (MRQ) i22.86-13.55
Market Capitalization
Market Capitalization i₹13.91B₹46.75B
Enterprise Value i₹13.61B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i21.0895.73
Enterprise to EBITDA i34.62-22.27
Risk & Other Metrics
Beta i0.940.19
Book Value per Share (MRQ) i₹1.38₹-10.63

Financial Statements Comparison: Shukra Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSHUKRAPHAR (2025)SPARC (2025)
Revenue/Sales i325.87M717.66M
Cost of Goods Sold i81.12M1.10B
COGS % of Revenue i24.9%153.2%
Gross Profit i244.76M-381.94M
Gross Margin i75.1%-53.2%
Research & Development i1.66MN/A
Operating Income (EBIT) i97.25M-3.34B
Operating Margin i29.8%-465.5%
EBITDA i168.63M-3.23B
EBITDA Margin i51.7%-450.0%
Pre-Tax Income i133.37M-3.43B
Pre-Tax Income % of Revenue i40.9%-477.6%
Income Tax i37.61M-2.72M
Income Tax % of Revenue i11.5%-0.4%
Net Income (Profit) i95.75M-3.43B
Profit Margin i29.4%-477.3%

Balance Sheet & Liquidity Metrics

MetricSHUKRAPHAR (2025)SPARC (2025)
Cash & Equivalents i121.18M19.64M
Total Current Assets i654.27M261.97M
Total Current Assets % of Revenue i200.8%36.5%
Total Current Liabilities i172.84M3.74B
Total Current Liabilities % of Revenue i53.0%521.5%
Long-Term Debt i31.13M1.07B
Long-Term Debt % of Revenue i9.6%149.0%
Total Shareholders Equity i628.36M-2.17B
Retained Earnings i143.00M-23.22B
Retained Earnings % of Revenue i43.9%-3,235.0%
Property, Plant & Equipment i193.97M178.02M

Cash Flow Statement Comparison

MetricSHUKRAPHAR (2025)SPARC (2025)
Operating Cash Flow i66.80M-3.48B
Operating Cash Flow % of Revenue i20.5%-485.5%
Capital Expenditures i-27.43M-97.45M
Free Cash Flow i51.75M-3.71B
FCF Margin i15.9%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHUKRAPHARSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i437.88M324.52M
Float Shares i46.25M91.32M
% Held by Insiders i89.33%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i10.67%24.48%

Dividend Analysis & Yield Comparison: Shukra Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricSHUKRAPHARSPARC
Last 12-Month Dividend i₹1.02N/A
Last 12-Month Dividend Yield i3.20%N/A
3-Year Avg Annual Dividend i₹0.35N/A
3-Year Avg Dividend Yield i3.91%N/A
3-Year Total Dividends i₹1.05N/A
Ex-Dividend DateSep 23, 2025N/A